131 related articles for article (PubMed ID: 11693258)
1. Advanced glycosylation end products induce nitric oxide synthase expression in C6 glioma cells: involvement of a p38 MAP kinase-dependent mechanism.
Lin CH; Lin YF; Chang MC; Wu CH; Ho YS; Lee HM
Life Sci; 2001 Oct; 69(21):2503-15. PubMed ID: 11693258
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway.
Chang PC; Chen TH; Chang CJ; Hou CC; Chan P; Lee HM
Kidney Int; 2004 May; 65(5):1664-75. PubMed ID: 15086905
[TBL] [Abstract][Full Text] [Related]
3. Chloroquine induces the expression of inducible nitric oxide synthase in C6 glioma cells.
Chen TH; Chang PC; Chang MC; Lin YF; Lee HM
Pharmacol Res; 2005 Apr; 51(4):329-36. PubMed ID: 15683746
[TBL] [Abstract][Full Text] [Related]
4. P38 MAPK, but not p42/p44 MAPK mediated inducible nitric oxide synthase expression in C6 glioma cells.
Xu X; Malave A
Life Sci; 2000 Nov; 67(26):3221-30. PubMed ID: 11191629
[TBL] [Abstract][Full Text] [Related]
5. Forskolin inhibits expression of inducible nitric oxide synthase mRNA via inhibiting the mitogen activated protein kinase in C6 cells.
Won JS; Lee JK; Suh HW
Brain Res Mol Brain Res; 2001 Apr; 89(1-2):1-10. PubMed ID: 11311970
[TBL] [Abstract][Full Text] [Related]
6. Involvement of p38 mitogen-activated protein kinase in PLL-AGE-induced cyclooxgenase-2 expression.
Lin CH; Wu CH; Thum WY; Ho YS; Lee HM
Eur J Pharmacol; 2002 Mar; 438(3):143-52. PubMed ID: 11909605
[TBL] [Abstract][Full Text] [Related]
7. Activation of Stat1 and subsequent transcription of inducible nitric oxide synthase gene in C6 glioma cells is independent of interferon-gamma-induced MAPK activation that is mediated by p21ras.
Nishiya T; Uehara T; Edamatsu H; Kaziro Y; Itoh H; Nomura Y
FEBS Lett; 1997 May; 408(1):33-8. PubMed ID: 9180263
[TBL] [Abstract][Full Text] [Related]
8. P38 mitogen-activated protein kinase inhibitor SB203580 has a bi-directional effect on iNOS expression and NO production.
Lahti A; Kankaanranta H; Moilanen E
Eur J Pharmacol; 2002 Nov; 454(2-3):115-23. PubMed ID: 12421638
[TBL] [Abstract][Full Text] [Related]
9. Lung, spleen, and kidney are the major places for inducible nitric oxide synthase expression in endotoxic shock: role of p38 mitogen-activated protein kinase in signal transduction of inducible nitric oxide synthase expression.
Kan W; Zhao KS; Jiang Y; Yan W; Huang Q; Wang J; Qin Q; Huang X; Wang S
Shock; 2004 Mar; 21(3):281-7. PubMed ID: 14770043
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycosylation end products induce NF-kappaB dependent iNOS expression in RAW 264.7 cells.
Wu CH; Huang CM; Lin CH; Ho YS; Chen CM; Lee HM
Mol Cell Endocrinol; 2002 Aug; 194(1-2):9-17. PubMed ID: 12242023
[TBL] [Abstract][Full Text] [Related]
11. Lipoteichoic acid induces nuclear factor-kappaB activation and nitric oxide synthase expression via phosphatidylinositol 3-kinase, Akt, and p38 MAPK in RAW 264.7 macrophages.
Kao SJ; Lei HC; Kuo CT; Chang MS; Chen BC; Chang YC; Chiu WT; Lin CH
Immunology; 2005 Jul; 115(3):366-74. PubMed ID: 15946254
[TBL] [Abstract][Full Text] [Related]
12. Regulation of inducible nitric oxide synthase expression in advanced glycation end product-stimulated raw 264.7 cells: the role of heme oxygenase-1 and endogenous nitric oxide.
Sumi D; Ignarro LJ
Diabetes; 2004 Jul; 53(7):1841-50. PubMed ID: 15220209
[TBL] [Abstract][Full Text] [Related]
13. Role of protein kinase C in BSA-AGE-mediated inducible nitric oxide synthase expression in RAW 264.7 macrophages.
Wu CH; Chang CH; Lin HC; Chen CM; Lin CH; Lee HM
Biochem Pharmacol; 2003 Jul; 66(2):203-12. PubMed ID: 12826263
[TBL] [Abstract][Full Text] [Related]
14. Involvement of JAK2 and MAPK on type II nitric oxide synthase expression in skin-derived dendritic cells.
Cruz MT; Duarte CB; Gonçalo M; Carvalho AP; Lopes MC
Am J Physiol; 1999 Dec; 277(6):C1050-7. PubMed ID: 10600756
[TBL] [Abstract][Full Text] [Related]
15. Radicicol suppresses expression of inducible nitric-oxide synthase by blocking p38 kinase and nuclear factor-kappaB/Rel in lipopolysaccharide-stimulated macrophages.
Jeon YJ; Kim YK; Lee M; Park SM; Han SB; Kim HM
J Pharmacol Exp Ther; 2000 Aug; 294(2):548-54. PubMed ID: 10900231
[TBL] [Abstract][Full Text] [Related]
16. Salicylate inhibition of extracellular signal-regulated kinases and inducible nitric oxide synthase.
Wang Z; Brecher P
Hypertension; 1999 Dec; 34(6):1259-64. PubMed ID: 10601128
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide plus 12-o-tetradecanoylphorbol 13-acetate induction of migration and invasion of glioma cells in vitro and in vivo: Differential inhibitory effects of flavonoids.
Shen SC; Lin CW; Lee HM; Chien LL; Chen YC
Neuroscience; 2006 Jun; 140(2):477-89. PubMed ID: 16580779
[TBL] [Abstract][Full Text] [Related]
18. Glutathione depletion in CYP2E1-expressing liver cells induces toxicity due to the activation of p38 mitogen-activated protein kinase and reduction of nuclear factor-kappaB DNA binding activity.
Wu D; Cederbaum A
Mol Pharmacol; 2004 Sep; 66(3):749-60. PubMed ID: 15322268
[TBL] [Abstract][Full Text] [Related]
19. Both p38alpha(MAPK) and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-1beta in rat glomerular mesangial cells.
Guan Z; Buckman SY; Springer LD; Morrison AR
J Biol Chem; 1999 Dec; 274(51):36200-6. PubMed ID: 10593906
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs).
Dukic-Stefanovic S; Gasic-Milenkovic J; Deuther-Conrad W; Münch G
J Neurochem; 2003 Oct; 87(1):44-55. PubMed ID: 12969251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
